reports
Dermapharm Holding SE: 1 director
A director at Dermapharm Holding SE bought 1,800,000 shares at 40.680EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
- Ahmed Ben Salem
TKA THYSSENKRUPP AG
EQNR EQUINOR ASA
MT ARCELORMITTAL SA
GALP GALP ENERGIA SGPS SA CLASS B
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
BFIT BASIC-FIT NV
SSAB A SSAB AB CLASS A
IDL ID LOGISTICS GROUP
UNIQA INSURANCE GROUP AG
SZG SALZGITTER AG
ITP INTERPARFUMS
SRP SRP GROUPE SA
VIRP VIRBAC SA
MRN MERSEN SA
VOE VOESTALPINE AG
BOSS HUGO BOSS AG
ACX ACERINOX SA
ENI ENI S.P.A.
ERA ERAMET SA
REP REPSOL SA
LNZ LENZING AG
NDA AURUBIS AG
RIEN ROYAL VOPAK NV
AMG RIETER HOLDING AG
WBD AMG ADVANCED METALLURGICAL GROUP N.V.
VIG WEBUILD S.P.A.
LTA VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
INSD ALTAMIR ACT PORTEUR
VLTSA VERIMATRIX SA
RIO VOLTALIA
BHP RIO TINTO PLC
RUI BHP GROUP LTD
BP. RUBIS SCA
DMP BP P.L.C.
AMAG DERMAPHARM HOLDING SE
SHEL AMAG AUSTRIA METALL AG
SHELL PLC
- Ahmed Ben Salem
TKA THYSSENKRUPP AG
EQNR EQUINOR ASA
MT ARCELORMITTAL SA
GALP GALP ENERGIA SGPS SA CLASS B
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
BFIT BASIC-FIT NV
SSAB A SSAB AB CLASS A
IDL ID LOGISTICS GROUP
STF STEF
UNIQA INSURANCE GROUP AG
SZG SALZGITTER AG
ITP INTERPARFUMS
SRP SRP GROUPE SA
VIRP VIRBAC SA
MRN MERSEN SA
VOE VOESTALPINE AG
BOSS HUGO BOSS AG
ACX ACERINOX SA
ENI ENI S.P.A.
ERA ERAMET SA
REP REPSOL SA
LNZ LENZING AG
MBWS MARIE BRIZARD WINE & SPIRITS SA
NDA AURUBIS AG
RIEN ROYAL VOPAK NV
AMG RIETER HOLDING AG
WBD AMG ADVANCED METALLURGICAL GROUP N.V.
VIG WEBUILD S.P.A.
LTA VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
INSD ALTAMIR ACT PORTEUR
VLTSA VERIMATRIX SA
RIO VOLTALIA
BHP RIO TINTO PLC
RUI BHP GROUP LTD
BP. RUBIS SCA
DMP BP P.L.C.
AMAG DERMAPHARM HOLDING SE
SHEL AMAG AUSTRIA METALL AG
SHELL PLC
- Oliver Metzger
- Stephan Wulf
EQS-News: Dermapharm Holding SE steigert den Umsatz planmäßig und über...
EQS-News: Dermapharm Holding SE / Schlagwort(e): Jahresergebnis/Vorläufiges Ergebnis Dermapharm Holding SE steigert den Umsatz planmäßig und übertrifft Prognose des bereinigten Konzern-EBITDAs 14.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE steigert den Umsatz planmäßig und übertrifft Prognose des bereinigten Konzern-EBITDAs Konzernumsatz erhöht sich um 4,0 % auf 1.180,8 Mio. € getrieben durch starkes organisches Wachstum im Segment „Markenarzneimittel“ Konzern-EBITDA (unbereinigt) steigt...
EQS-News: Dermapharm Holding SE increases revenue as projected and exc...
EQS-News: Dermapharm Holding SE / Key word(s): Annual Results/Preliminary Results Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA 14.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA Consolidated revenue up 4.0% to EUR 1,180.8 million, driven by strong organic growth in the "Branded pharmaceuticals" segment Above-average increase in unadjusted consolidated E...
- Amira Manai
- Jerôme Bodin
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
APAML APERAM SA
EVT EVOTEC SE
GBF BILFINGER SE
SCR SCOR SE
BLC BASTIDE LE CONFORT MEDICAL SA
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
ENI ENI S.P.A.
MBB MBB INDUSTRIES SE
XIOR XIOR STUDENT HOUSING N.V.
REP REPSOL SA
ERG ERG S.P.A.
CARM CARMILA SAS
LTA ALTAMIR ACT PORTEUR
RENE REDES ENERGETICAS NACIONAIS SA
COL INMOBILIARIA COLONIAL SOCIMI SA
BP. BP P.L.C.
DMP DERMAPHARM HOLDING SE
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
S92 SMA SOLAR TECHNOLOGY AG
VK VALLOUREC SA
NA9 NAGARRO
AERO MONTANA AEROSPACE AG
MRX MISTER SPEX SE
NVM NOVEM GROUP SA
SHEL SHELL PLC
CO CASINO GUICHARD-PERRACHON
- Amira Manai
- Jerôme Bodin
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
APAML APERAM SA
EVT EVOTEC SE
GBF BILFINGER SE
SCR SCOR SE
BLC BASTIDE LE CONFORT MEDICAL SA
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
ENI ENI S.P.A.
MBB MBB INDUSTRIES SE
XIOR XIOR STUDENT HOUSING N.V.
REP REPSOL SA
ERG ERG S.P.A.
CARM CARMILA SAS
LTA ALTAMIR ACT PORTEUR
RENE REDES ENERGETICAS NACIONAIS SA
COL INMOBILIARIA COLONIAL SOCIMI SA
BP. BP P.L.C.
DMP DERMAPHARM HOLDING SE
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
S92 SMA SOLAR TECHNOLOGY AG
VK VALLOUREC SA
NA9 NAGARRO
AERO MONTANA AEROSPACE AG
MRX MISTER SPEX SE
NVM NOVEM GROUP SA
SHEL SHELL PLC
CO CASINO GUICHARD-PERRACHON
- Oliver Metzger
- Stephan Wulf
Dermapharm Holding SE : Strong 9M results, increased earnings quality ...
>Strong 9M reflected first improvements of Other Healthcare Products… - Dermapharm released a set of strong 9M figures, which were basically supported by all divisions. 9M sales of € 890m (+3%) came in 1% above our (€ 886m) and 2% above the consensus compiled by the company of € 871m. Adjusted EBITDA of € 240m (-1%) was 5% above our estimates of € 229m and 8% above the consensus of € 223m. The slightly lower profitability vs 9M 2023 (adjusted EBITDA margin of 27% vs 2...
- Oliver Metzger
- Stephan Wulf
Dermapharm Holding SE : All divisions contribute to better-than-expect...
>A strong set of 9M figures beats expectations - 9M sales of € 890m (+3%) came in 1% above our (€ 886m) and 2% above the consensus compiled by the company of € 871m. Adjusted EBITDA of € 240m (-1%) is 5% above our estimates of € 229m and 8% above consensus of € 223m. The slightly lower profitability vs 9M 2023 (adjusted EBITDA margin of 27% vs 28%) still reflects the absence of sales from the extremely attractive contract with BioNTech, which still supported Q1 2023....
EQS-News: Dermapharm Holding SE mit starkem dritten Quartal 2024, die ...
EQS-News: Dermapharm Holding SE / Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen Dermapharm Holding SE mit starkem dritten Quartal 2024, die französische Arkopharma erstmals wieder mit gestiegenem EBITDA gegenüber Vorjahr 14.11.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE mit starkem dritten Quartal 2024, die französische Arkopharma erstmals wieder mit gestiegenem EBITDA gegenüber Vorjahr Konzernumsatz erhöht sich um 2,7 % auf 890,1 Mio. €. Das Wachstum der margenstarken „Markenarz...
EQS-News: Dermapharm Holding SE posts strong results for Q3 2024, Arko...
EQS-News: Dermapharm Holding SE / Key word(s): Quarterly / Interim Statement/9 Month figures Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time 14.11.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time Consolidated revenue up 2.7% to EUR 890.1 million. Growth in high-margin "Branded pharmaceuticals" more than offsets declining r...
EQS-News: Dermapharm Holding SE: Margenstarkes Bestandsgeschäft des Ma...
EQS-News: Dermapharm Holding SE / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht Dermapharm Holding SE: Margenstarkes Bestandsgeschäft des Markensegments treibt organisches Wachstum in deutschen und internationalen Gesellschaften 27.08.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE: Margenstarkes Bestandsgeschäft des Markensegments treibt organisches Wachstum in deutschen und internationalen Gesellschaften Beeindruckendes organisches Wachstum des Bestandsgeschäfts im Markensegment in deuts...
EQS-News: Dermapharm Holding SE: High-margin existing business in bran...
EQS-News: Dermapharm Holding SE / Key word(s): Half Year Results/Half Year Report Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies 27.08.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies Impressive organic growth in existing branded pharmaceuticals business at German and internation...
EQS-News: Nachhaltiges organisches Wachstum im margenstarken Bestandsg...
EQS-News: Dermapharm Holding SE / Schlagwort(e): Halbjahresergebnis/Vorläufiges Ergebnis Nachhaltiges organisches Wachstum im margenstarken Bestandsgeschäft der Markenarzneimittel 14.08.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE: Nachhaltiges organisches Wachstum im margenstarken Bestandsgeschäft der Markenarzneimittel Starkes organisches Wachstum im Bestandsgeschäft der Markenarzneimittel in nahezu allen Märkten kompensiert das planmäßige Ende der pandemischen Phase der Impfstoffkooperation...
EQS-News: Sustained organic growth in high-margin existing branded pha...
EQS-News: Dermapharm Holding SE / Key word(s): Half Year Results/Preliminary Results Sustained organic growth in high-margin existing branded pharmaceutical business 14.08.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE: Sustained organic growth in high- margin existing branded pharmaceutical business Strong organic growth of existing branded pharmaceutical business across virtually every market compensates for effects from scheduled end of pandemic phase in vaccine cooperation Consolidated revenue an...
EQS-News: Dermapharm Holding SE: Hauptversammlung beschließt Dividende...
EQS-News: Dermapharm Holding SE / Schlagwort(e): Hauptversammlung Dermapharm Holding SE: Hauptversammlung beschließt Dividendenausschüttung in Höhe von 0,88 € je Aktie 27.06.2024 / 18:15 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE: Hauptversammlung beschließt Dividendenausschüttung in Höhe von 0,88 € je Aktie Prognose für 2024 bestätigt Vorstand und Aufsichtsrat mit großer Mehrheit entlastet Aktionäre beschließen Dividendenzahlung in Höhe von 0,88 € je Stückaktie Ausschüttungsquote von rund 78 % des Ko...
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves divid...
EQS-News: Dermapharm Holding SE / Key word(s): AGM/EGM Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share 27.06.2024 / 18:15 CET/CEST The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share 2024 outlook confirmed Board of Management and Supervisory Board actions ratified with large majority Shareholders resolve dividend payment of EUR 0.88 per share Distribution ratio: approximately 78% of consolidated net...
- Jerôme Bodin
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 05/16/2024
We have tactically downgraded the energy sector from Overweight to Neutral (excl. oil services on which we are maintaining our Overweight rating) and dropped Shell Plc from our Large Caps list. The IEA report has accelerated the downswing for the energy sector, which could continue in the days ahead. June will be a better month to come back to the sector. - ...
FP TOTAL SE
EQNR EQUINOR ASA
ELIOR ELIOR GROUP SA
GALP GALP ENERGIA SGPS SA CLASS B
ALFOC FOCUS HOME INTERACTIVE SA
GYC GRAND CITY PROPERTIES SA
GLJ GRENKE AG
DEC JCDECAUX SA
BLC BASTIDE LE CONFORT MEDICAL SA
JCQ JACQUET METALS SA
ENI ENI S.P.A.
REP REPSOL SA
VASTN VASTNED RETAIL NV
ERG ERG S.P.A.
CPINV CARE PROPERTY INVEST SA
DIC DIC ASSET AG
FNTN FREENET AG
DUFN DUFRY AG
BP. BP P.L.C.
MDM MAISONS DU MONDE SA
JST JOST WERKE AG
DMP DERMAPHARM HOLDING SE
VK VALLOUREC SA
SHEL SHELL PLC
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
- Jerôme Bodin
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 16/05/2024
Nous dégradons tactiquement à Neutre le secteur de l’énergie (hors Services Pétroliers sur lesquels nous conservons une opinion Surperformance) et faisons sortir Shell plc de notre liste Large Caps. Le rapport AIE a accéléré la baisse du secteur énergie, qui pourrait se poursuivre dans les jours qui viennent. Juin sera un meilleur mois pour revenir sur le secteur. - ...
FP TOTAL SE
EQNR EQUINOR ASA
ELIOR ELIOR GROUP SA
GALP GALP ENERGIA SGPS SA CLASS B
ALFOC FOCUS HOME INTERACTIVE SA
GYC GRAND CITY PROPERTIES SA
GLJ GRENKE AG
DEC JCDECAUX SA
BLC BASTIDE LE CONFORT MEDICAL SA
JCQ JACQUET METALS SA
ENI ENI S.P.A.
REP REPSOL SA
VASTN VASTNED RETAIL NV
ERG ERG S.P.A.
CPINV CARE PROPERTY INVEST SA
DIC DIC ASSET AG
FNTN FREENET AG
DUFN DUFRY AG
RUI RUBIS SCA
BP. BP P.L.C.
MDM MAISONS DU MONDE SA
JST JOST WERKE AG
DMP DERMAPHARM HOLDING SE
VK VALLOUREC SA
SHEL SHELL PLC
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.